Letter to the Editor
Author’s response to commentary on the PHANTASi trial
Abstract
We read, with interest, the letters to editor by Rello et al. (1) and Bolliger et al. (2) in response to our Prehospital Antibiotics Against Sepsis (PHANTASi) trial which was recently published in the Lancet Respiratory Medicine (3).